Immunogenicity of viral and non-viral genetic medicines
24 Jun 2025
Gene Therapy Development
- Increasing the safety of genetic medicines by deimmunization, improved production, and product characterization
- Assays to evaluate and derisk vector immunogenicity before and after drug administration
- Current approaches to downregulate host immunity and increase safety
Industry Expert
